GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Almujtama Alraida Medical Co (SAU:9592) » Definitions » Debt-to-EBITDA

Almujtama Alraida Medical Co (SAU:9592) Debt-to-EBITDA : 0.00 (As of . 20)


View and export this data going back to 2023. Start your Free Trial

What is Almujtama Alraida Medical Co Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Almujtama Alraida Medical Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was ﷼0.00 Mil. Almujtama Alraida Medical Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was ﷼0.00 Mil. Almujtama Alraida Medical Co's annualized EBITDA for the quarter that ended in . 20 was ﷼0.00 Mil.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Almujtama Alraida Medical Co's Debt-to-EBITDA or its related term are showing as below:

SAU:9592's Debt-to-EBITDA is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 2.555
* Ranked among companies with meaningful Debt-to-EBITDA only.

Almujtama Alraida Medical Co Debt-to-EBITDA Historical Data

The historical data trend for Almujtama Alraida Medical Co's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Almujtama Alraida Medical Co Debt-to-EBITDA Chart

Almujtama Alraida Medical Co Annual Data
Trend
Debt-to-EBITDA

Almujtama Alraida Medical Co Semi-Annual Data
Debt-to-EBITDA

Competitive Comparison of Almujtama Alraida Medical Co's Debt-to-EBITDA

For the Pharmaceutical Retailers subindustry, Almujtama Alraida Medical Co's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Almujtama Alraida Medical Co's Debt-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Almujtama Alraida Medical Co's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Almujtama Alraida Medical Co's Debt-to-EBITDA falls into.



Almujtama Alraida Medical Co Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Almujtama Alraida Medical Co's Debt-to-EBITDA for the fiscal year that ended in . 20 is calculated as

Almujtama Alraida Medical Co's annualized Debt-to-EBITDA for the quarter that ended in . 20 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is one times the quarterly (. 20) EBITDA data.


Almujtama Alraida Medical Co  (SAU:9592) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Almujtama Alraida Medical Co Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Almujtama Alraida Medical Co's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Almujtama Alraida Medical Co (SAU:9592) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Main Street, P.O. Box 109474, Al-Hamadania District, Jeddah, SAU, 21351
Almujtama Alraida Medical Co is a company having its core operations include operating pharmacies and retail in pharmaceutical products such as medicines and cosmetic products and medical equipment and medical supplies. It also provides pharmaceutical services in the Kingdom of Saudi Arabia. The Company also has an electronic pharmacy through which sales are made online through the Company's website, including providing free delivery service to customers.

Almujtama Alraida Medical Co (SAU:9592) Headlines

No Headlines